Doxorubicin-13C,d3(Synonyms: Hydroxydaunorubicin-13C,d3)

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白、同位素标记物，专注于信号通路和疾病研究领域。
Doxorubicin-13C,d3 (Synonyms: Hydroxydaunorubicin-13C,d3)

Doxorubicin-13C,d3 是 13C 标记的 Doxorubicin 的氘代物。 Doxorubicin (Hydroxydaunorubicin) 是一种有细胞毒性的蒽环类抗生素，常用作肿瘤化疗剂。Doxorubicin 抑制拓扑异构酶 II (topoisomerase-II)，IC₅₀ 为 2.67 μM，从而抑制 DNA 复制。Doxorubicin 下调 AMPK 的基础磷酸化以及下游 acetyl-CoA 羧化酶。Do

Doxorubicin-13C,d3 Chemical Structure

规格		是否有货
100 mg		询价
250 mg		询价
500 mg		询价

* Please select Quantity before adding items.

生物活性	Doxorubicin-13C,d3 is the deuterium and 13C labeled Doxorubicin. Doxorubicin (Hydroxydaunorubicin), a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin inhibits topoisomerase II with an IC50 of 2.67 μM, thus stopping DN
体外研究 (In Vitro)	Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs^[1]. Shanghai Jinpan Biotech Co Ltd has not independently confirmed the accuracy of these methods. They are for reference only.
分子量	547.53
Formula	C₂₆¹³CH₂₆D₃NO₁₁
中文名称	阿霉素 13C,d3；多柔比星 13C,d3
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Please store the product under the recommended conditions in the Certificate of Analysis.
纯度 & 产品资料	Data Sheet (482 KB) 产品使用指南 (1538 KB)
参考文献	[1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019 Feb;53(2):211-216. [2]. Nitiss JL, et al. Targeting DNA topoisomerase II in cancer chemotherapy.Nat Rev Cancer. 2009 May;9(5):338-50.;Rhee HK, et al. Synthesis, cytotoxicity, and DNA topoisomerase II inhibitory activity of benzofuroquinolinediones. Bioorg Med Chem. 2007 Feb 15;1

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务